Citations 1
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL
Nowakowski, Grzegorz S. , Willenbacher, Wolfgang , Greil, Richard , Larsen, Thomas Stauffer , Manges, Robert, Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh , Knoble, Jeanna, Jørgensen, Judit , Rubio, Neus Domper, Casadebaig, Marie‐Laure, Manzke, Oliver, Cunningham, David , Patel, Krish , Jäger, Ulrich , Haïoun, Corinne , Brown, Peter de Nully , Cunningham, David , Muñoz, Javier
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 132-134
